UCI researchers discover new drugs with poten

In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinitis pigmentosa (RP).

Related Keywords

California ,United States ,Irvine ,Krzysztof Palczewski ,Jennings Luu ,National Institutes Of Health ,Research To Prevent Blindness ,Proceedings Of The National Academy Sciences ,Veale Institute For Entrepreneurship ,Polgenix Inc ,A University Of California ,Wayfinder Incubator Program ,Hyperion Therapeutics Inc ,School Of Medicine ,Scholar At University Of California ,International Centre For Translational Eye Research ,Liaison Committee On Medical Accreditation ,Us Department Of Veterans Affairs ,National Academy ,Stress Resilience Enhancing Drug ,Donald Bren Professor ,Phd Doctoral Fellow ,Medical Scientist Training Program ,Case Western Reserve University ,Visiting Scholar ,National Institutes ,Veterans Affairs ,International Centre ,Translational Eye Research ,Hyperion Therapeutics ,Morganthaler Pavey Startup Competition ,Veale Institute ,Applied Innovation ,Health Education ,Advance Leaders ,Integrative Medicine ,Leadership Education ,Advance Diversity African ,Medical Education ,Latino Community ,Liaison Committee ,Medical Accreditation ,Chief Scientific Officer ,